Ignite Creation Date:
2024-05-06 @ 7:40 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06094296
Status:
COMPLETED
Last Update Posted:
2024-06-25
First Post:
2023-10-17
Brief Title:
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer NSCLC
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb